Orthobiologics Market Research Report - Global Forecast till 2027

Global Orthobiologics Market Report: Information by Product (Demineralized Bone Matrix, Bone Morphogenetic Protein), Application (Osteoarthritis & Degenerative Arthritis, Spinal Fusion), End User (Hospitals, Orthopedic Clinics)—Global Forecast till 2027

ID: MRFR/HC/6356-HCR | February 2021 | Region: Global | 85 pages

Please note that the assessment period of report has been updated from 2019-2024 to 2020-2027. Cordially fill the sample form for updated data.

Orthobiologics Market Scenario


The Global Orthobiologics Market is accounted for USD 4,964 million in 2019 and expected to register 5.6% CAGR during the forecast period (2019–2024).


Orthobiologics are substances that are used by orthopedic surgeons to heal injuries more quickly. The orthobiologics are used to improve the tendons, ligaments, healing of broken bones and injured muscles. Also, these products are derived from substances that are naturally found in the body. When they are used in higher concentrations, orthobiologic substances help speed up the healing process.


The increasing cases of trauma and sports injury, demand for biologics in minimally invasive procedures, approval of products, and raising awareness are expected to drive the growth of the global orthobiologics market during the forecast period. Moreover, emerging technological innovations in biomaterials, rising obese and geriatric population, and rising research and development activities by top players such as mergers, expansion, and collaboration for the development of new products and launches by major players are also boosting the growth of the market. For instance, according to the data provided by U.S. Department of Commerce, in 2015, the total population above the age 60 was around 902.28 million, whereas, in 2018, the total population above the age of 60 are around 991.24 million. The population above 60’s year are growing with a rate of 3.18% per years.


However, less reimbursement policy may hamper the growth of the market during the assessment period.


Orthobiologics Market Segmentation


The global orthobiologics market has been segmented on the basis of product, application, end-user, and region.


On the basis of product, the market has been classified as a Demineralized bone matrix (DBM), Bone morphogenetic protein (BPM), Allograft, Viscosupplementation products, Synthetic bone substitutes, and Others.


Based on application, the market has been divided into Osteoarthritis & degenerative arthritis, Spinal fusion, Fracture recovery, Soft tissue injuries, and Others. By application spinal fusion segment dominant, the market in 2018 due to increasing sports-related injuries, the prevalence of spine and traumatic injuries, and accidents.


By end user, the market has been segmented into Hospitals, Orthopedic Clinics, and Others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The orthobiologics market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European orthobiologics market has been segmented into Western Europe and Eastern Europe. Western Europe has been sub-segmented into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The orthobiologics market in Asia-Pacific has been divided into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The orthobiologics market in the Middle East & Africa has been segmented into the Middle East and Africa.


Orthobiologics Regional Market Summary


FIGURE 1 Global Orthobiologics Market Share, by Region, 2018 (%)

Source: MRFR Analysis


Americas is likely to dominate the orthobiologics market during the forecast period owing to the advanced technologies, increasing funding & investments by major players, and rising prevalence of sports-related injuries & injuries caused due to falls and accidents. For instance, according to the report published by the American Orthopaedic Society for Sports Medicine in 2017, around 3.5 million kids below age 14 obtain medical treatment for sports injuries each year.


The European are likely to be the second-largest market in the global orthobiologics market owing to the rising geriatric population, government funding and support of the healthcare sector coupled with increasing research and development, and rising awareness.


The Asia-Pacific market is expected to hold a significant share in the orthobiologics market. The market growth in this region can be attributed to the rise in demand for advanced treatment, awareness of orthobiologics, and rising investments in healthcare. Also, countries such as India and China are considering the fastest growing region due to a government focused toward adopting advance treatment from a developed country.


The market in the Middle East & Africa is expected to account for the smallest share of the global orthobiologics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Orthobiologics Market Key Players

Some of the key players in the global orthobiologics market are Arthrex, Inc., Exactech, Inc., Globus Medical Inc., Integra LifeSciences, Johnson & Johnson, Medline Industries, Inc., NuVasive, Inc., Stryker Corporation, Wright Medical Group N.V., Zimmer Biomet, and Others


 Global Orthobiologics Market, by Product


  • Demineralized bone matrix (DBM)

  • Bone morphogenetic protein (BPM)

  • Allograft

  • Viscosupplementation products

  • Synthetic bone substitutes

  • Others

Global Orthobiologics Market, by Application


  • Osteoarthritis & degenerative arthritis

  • Spinal fusion

  • Fracture recovery

  • Soft tissue injuries

  • Others

Global Orthobiologics Market, by End User


  • Hospitals

  • Orthopedic Clinics

  • Others


Global Orthobiologics Market, by Region


  • Americas

    • North America

      • US

      • Canada



    • Latin America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Company Profiles       



  • Arthrex, Inc.

  • Exactech, Inc.

  • Globus Medical Inc

  • Integra LifeSciences

  • Johnson & Johnson

  • Medline Industries, Inc

  • NuVasive, Inc.

  • Stryker Corporation

  • Wright Medical Group N.V.

  • Zimmer Biomet

  • Others


Intended Audience



  • Orthobiologics Products Manufacturers

  • Orthobiologics Products Distributors and Suppliers

  • Healthcare Providers

  • Research Institutes and Academic Centers

  • Medical Devices Manufacturers

  • Government Associations

  • Market Research and Consulting 



Frequently Asked Questions (FAQ) :


Orthobiologics market was valued at USD 4.9 billion in 2019.

Orthobiologics market is expected to exhibit a strong 5.6% CAGR over the forecast period from 2019 to 2024.

The increasing demand for effective trauma healing agents for sports and muscle injuries is the major driver for the orthobiologics market.

The Americas is the leading regional market for orthobiologics.

Leading players in the orthobiologics market include Exactech, Arthrex, Globus Medical, Wright Medical Group, and Integra LifeSciences, among others.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

Chapter 3. Research Methodology

3.1. Introduction

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

Chapter 4. Market Dynamics

4.1. Drivers

4.2. Restraints

4.3. Opportunities

4.4. Challenges

4.5. Macroeconomic Indicators

Chapter 5. Market Factor Analysis

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. Investment Feasibility Analysis

Chapter 6. Global Orthobiologics Market, by Product

6.1. Introduction

6.2. Demineralized bone matrix (DBM)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3. Bone morphogenetic protein (BPM)

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.4. Allograft

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.5. Viscosupplementation products

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.6. Synthetic bone substitutes

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.7. Others

Chapter 7. Global Orthobiologics Market, by Application

7.1. Introduction

7.2. Osteoarthritis & degenerative arthritis

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3. Spinal fusion

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.4. Fracture recovery

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.5. Soft tissue injuries

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.6. Others

Chapter 8. Global Orthobiologics Market, by End User

8.1. Introduction

8.2. Hospitals

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3. Orthopedic Clinics

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4. Others

Chapter 9. Global Orthobiologics Market, by Region

9.1. Introduction

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

Chapter 10. Company Landscape

10.1. Introduction

10.2. Market Share Analysis

10.3. Key Developments & Strategies

Chapter 11. Company Profiles

11.1. Arthrex, Inc.

11.1.1. Company Overview

11.1.2. Product Overview

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Exactech, Inc.

11.2.1. Company Overview

11.2.2. Product Overview

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Globus Medical Inc

11.3.1. Company Overview

11.3.2. Product Overview

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Integra LifeSciences

11.4.1. Company Overview

11.4.2. Product Overview

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Johnson & Johnson

11.5.1. Company Overview

11.5.2. Product Overview

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Medline Industries, Inc

11.6.1. Company Overview

11.6.2. Product Overview

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. NuVasive, Inc.

11.7.1. Company Overview

11.7.2. Product Overview

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Stryker Corporation

11.8.1. Company Overview

11.8.2. Product Overview

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Wright Medical Group N.V.

11.9.1. Company Overview

11.9.2. Product Overview

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Zimmer Biomet

11.10.1. Company Overview

11.10.2. Product Overview

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Others

Chapter 12. MRFR Conclusion

12.1. Key Findings

12.1.1. From CEO’s Viewpoint

12.1.2. Unmet Needs of the Market

12.2. Key Companies to Watch

12.3. Predictions for the Orthobiologics Industry

Chapter 13. Appendix


LIST OF TABLES

Table 1. Global Orthobiologics Market Synopsis, 2020–2027

Table 2. Global Orthobiologics Market Estimates and Forecast, 2020–2027 (USD Million)

Table 3. Global Orthobiologics Market, by Region, 2020–2027 (USD Million)

Table 4. Global Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 5. Global Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 6. Global Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 7. North America: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 8. North America: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 9. North America: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 10. US: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 11. US: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 12. US: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 13. Canada: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 14. Canada: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 15. Canada: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 16. Latin America: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 17. Latin America: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 18. Latin America: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 19. Europe: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 20. Europe: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 21. Europe: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 22. Western Europe: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 23. Western Europe: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 24. Western Europe: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 25. Eastern Europe: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 26. Eastern Europe: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 27. Eastern Europe: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 28. Asia-Pacific: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 29. Asia-Pacific: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 30. Asia-Pacific: Orthobiologics Market, by End User, 2020–2027 (USD Million)

Table 31. Middle East & Africa: Orthobiologics Market, by Product, 2020–2027 (USD Million)

Table 32. Middle East & Africa: Orthobiologics Market, by Application, 2020–2027 (USD Million)

Table 33. Middle East & Africa: Orthobiologics Market, by End User, 2020–2027 (USD Million)

LIST OF FIGURES

Figure 1. Research Process

Figure 2. Segmentation for Global Orthobiologics Market

Figure 3. Segmentation Market Dynamics for Global Orthobiologics Market

Figure 4. Global Orthobiologics Market Share, by Product, 2020

Figure 5. Global Orthobiologics Market Share, by Application, 2020

Figure 6. Global Orthobiologics Market Share, by End User, 2020

Figure 7. Global Orthobiologics Market Share, by Region, 2020

Figure 8. North America: Orthobiologics Market Share, by Country, 2020

Figure 9. Europe: Orthobiologics Market Share, by Country, 2020

Figure 10. Asia-Pacific: Orthobiologics Market Share, by Country, 2020

Figure 11. Middle East & Africa: Orthobiologics Market Share, by Country, 2020

Figure 12. Global Orthobiologics Market: Company Share Analysis, 2020 (%)

Figure 13. Arthrex, Inc.: Key Financials

Figure 14. Arthrex, Inc.: Segmental Revenue

Figure 15. Arthrex, Inc.: Geographical Revenue

Figure 16. Exactech, Inc.: Key Financials

Figure 17. Exactech, Inc.: Segmental Revenue

Figure 18. Exactech, Inc.: Geographical Revenue

Figure 19. Globus Medical Inc: Key Financials

Figure 20. Globus Medical Inc: Segmental Revenue

Figure 21. Globus Medical Inc: Geographical Revenue

Figure 22. Integra LifeSciences: Key Financials

Figure 23. Integra LifeSciences: Segmental Revenue

Figure 24. Integra LifeSciences: Geographical Revenue

Figure 25. Johnson & Johnson: Key Financials

Figure 26. Johnson & Johnson: Segmental Revenue

Figure 27. Johnson & Johnson: Geographical Revenue

Figure 28. Medline Industries, Inc: Key Financials

Figure 29. Medline Industries, Inc: Segmental Revenue

Figure 30. Medline Industries, Inc: Geographical Revenue

Figure 31. NuVasive, Inc.: Key Financials

Figure 32. NuVasive, Inc.: Segmental Revenue

Figure 33. NuVasive, Inc.: Geographical Revenue

Figure 34. Stryker Corporation: Key Financials

Figure 35. Stryker Corporation: Segmental Revenue

Figure 36. Stryker Corporation: Geographical Revenue

Figure 37. Wright Medical Group N.V.: Key Financials

Figure 38. Wright Medical Group N.V.: Segmental Revenue

Figure 39. Wright Medical Group N.V.: Geographical Revenue

Figure 40. Wright Medical Group N.V.: Key Financials

Figure 41. Wright Medical Group N.V.: Segmental Revenue

Figure 42. Wright Medical Group N.V.: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.